229 related articles for article (PubMed ID: 29872083)
21. Subcellular localization of fibroblast growth factor receptor type 2 and correlation with CTNNB1 genotype in adrenocortical carcinoma.
Haase M; Thiel A; Scholl UI; Ashmawy H; Schott M; Ehlers M
BMC Res Notes; 2020 Jun; 13(1):282. PubMed ID: 32522271
[TBL] [Abstract][Full Text] [Related]
22. Integrated genomic characterization of adrenocortical carcinoma.
Assié G; Letouzé E; Fassnacht M; Jouinot A; Luscap W; Barreau O; Omeiri H; Rodriguez S; Perlemoine K; René-Corail F; Elarouci N; Sbiera S; Kroiss M; Allolio B; Waldmann J; Quinkler M; Mannelli M; Mantero F; Papathomas T; De Krijger R; Tabarin A; Kerlan V; Baudin E; Tissier F; Dousset B; Groussin L; Amar L; Clauser E; Bertagna X; Ragazzon B; Beuschlein F; Libé R; de Reyniès A; Bertherat J
Nat Genet; 2014 Jun; 46(6):607-12. PubMed ID: 24747642
[TBL] [Abstract][Full Text] [Related]
23. β-catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma.
Gaujoux S; Grabar S; Fassnacht M; Ragazzon B; Launay P; Libé R; Chokri I; Audebourg A; Royer B; Sbiera S; Vacher-Lavenu MC; Dousset B; Bertagna X; Allolio B; Bertherat J; Tissier F
Clin Cancer Res; 2011 Jan; 17(2):328-36. PubMed ID: 21088256
[TBL] [Abstract][Full Text] [Related]
24. Identification of CTNNB1 mutations, CTNNB1 amplifications, and an Axin2 splice variant in juvenile angiofibromas.
Wemmert S; Willnecker V; Kulas P; Weber S; Lerner C; Berndt S; Wendler O; Schick B
Tumour Biol; 2016 Apr; 37(4):5539-49. PubMed ID: 26572152
[TBL] [Abstract][Full Text] [Related]
25. Altered expression of noncanonical Wnt pathway genes in paediatric and adult adrenocortical tumours.
Mermejo LM; Leal LF; Colli LM; Fragoso MC; Latronico AC; Tone LG; Scrideli CA; Tucci S; Martinelli CE; Yunes JA; Mastellaro MJ; Seidinger AL; Brandalise SR; Moreira AC; Ramalho LN; Antonini SR; Castro M
Clin Endocrinol (Oxf); 2014 Oct; 81(4):503-10. PubMed ID: 24717047
[TBL] [Abstract][Full Text] [Related]
26. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
[TBL] [Abstract][Full Text] [Related]
27. Wnt/β-catenin activation cooperates with loss of p53 to cause adrenocortical carcinoma in mice.
Borges KS; Pignatti E; Leng S; Kariyawasam D; Ruiz-Babot G; Ramalho FS; Taketo MM; Carlone DL; Breault DT
Oncogene; 2020 Jul; 39(30):5282-5291. PubMed ID: 32561853
[TBL] [Abstract][Full Text] [Related]
28. Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas.
Ragazzon B; Libé R; Assié G; Tissier F; Barreau O; Houdayer C; Perlemoine K; Audebourg A; Clauser E; René-Corail F; Bertagna X; Dousset B; Bertherat J; Groussin L
Eur J Endocrinol; 2014 Mar; 170(3):385-91. PubMed ID: 24347427
[TBL] [Abstract][Full Text] [Related]
29. Activation of the Wnt/β-catenin pathway is common in wilms tumor, but rarely through β-catenin mutation and APC promoter methylation.
Schweigert A; Fischer C; Mayr D; von Schweinitz D; Kappler R; Hubertus J
Pediatr Surg Int; 2016 Dec; 32(12):1141-1146. PubMed ID: 27679509
[TBL] [Abstract][Full Text] [Related]
30. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
[TBL] [Abstract][Full Text] [Related]
31. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
[TBL] [Abstract][Full Text] [Related]
32. Cushing's syndrome in an infant secondary to malignant adrenocortical tumors with somatic mutation of beta-catenin.
Pusantisampan T; Sangkhathat S; Kayasut K; Kanngurn S; Jaruratanasirikul S; Chotsampancharoen T; Kritsaneepaiboon S
Pediatr Dev Pathol; 2010; 13(3):238-42. PubMed ID: 19863445
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological analysis of β-catenin and Axin-1 in solid pseudopapillary neoplasms of the pancreas.
Huang SC; Ng KF; Yeh TS; Chang HC; Su CY; Chen TC
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S438-46. PubMed ID: 21769465
[TBL] [Abstract][Full Text] [Related]
35. No evidence for involvement of beta-catenin and APC in urothelial carcinomas.
Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A
Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582
[TBL] [Abstract][Full Text] [Related]
36. Wnt/β-catenin signal alteration and its diagnostic utility in basal cell adenoma and histologically similar tumors of the salivary gland.
Sato M; Yamamoto H; Hatanaka Y; Nishijima T; Jiromaru R; Yasumatsu R; Taguchi K; Masuda M; Nakagawa T; Oda Y
Pathol Res Pract; 2018 Apr; 214(4):586-592. PubMed ID: 29496310
[TBL] [Abstract][Full Text] [Related]
37. Investigation of BRAF and CTNNB1 activating mutations in adrenocortical tumors.
Masi G; Lavezzo E; Iacobone M; Favia G; Palù G; Barzon L
J Endocrinol Invest; 2009 Jul; 32(7):597-600. PubMed ID: 19498322
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of Wnt signaling molecules in ameloblastoma with aberrant nuclear expression of beta-catenin.
Tanahashi J; Daa T; Yada N; Kashima K; Kondoh Y; Yokoyama S
J Oral Pathol Med; 2008 Oct; 37(9):565-70. PubMed ID: 18284543
[TBL] [Abstract][Full Text] [Related]
39. Expression of Wnt and TGF-β pathway components and key adrenal transcription factors in adrenocortical tumors: association to carcinoma aggressiveness.
Parviainen H; Schrade A; Kiiveri S; Prunskaite-Hyyryläinen R; Haglund C; Vainio S; Wilson DB; Arola J; Heikinheimo M
Pathol Res Pract; 2013 Aug; 209(8):503-9. PubMed ID: 23866946
[TBL] [Abstract][Full Text] [Related]
40. Microcystic Stromal Tumor: A Distinctive Ovarian Sex Cord-Stromal Neoplasm Characterized by FOXL2, SF-1, WT-1, Cyclin D1, and β-catenin Nuclear Expression and CTNNB1 Mutations.
Irving JA; Lee CH; Yip S; Oliva E; McCluggage WG; Young RH
Am J Surg Pathol; 2015 Oct; 39(10):1420-6. PubMed ID: 26200099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]